- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.10. | Rocket aborts FDA filing for Fanconi gene therapy | ||
| 03.10. | Cidara gets $339m BARDA award for flu prophylactic | ||
| 03.10. | GLP-1s from Novo, Lilly 'should be first-line in obesity' | ||
| 03.10. | Jazz Pharma, Roche combo cleared by FDA for lung cancer | ||
| 03.10. | FDA angers anti-abortion lobby with generic abortion pill OK | ||
| 02.10. | Pharma tariffs yet to emerge as Trump seeks more deals | ||
| 02.10. | Three more pharmas join OpenFold3 AI consortium | ||
| 01.10. | Crystalys emerges with $205m, and other biofinancings | ||
| 01.10. | Indivior stops Opvee promotion in New York after settlement | ||
| 01.10. | Sanofi faces EU antitrust probe into vaccine business | ||
| 01.10. | Umoja's in vivo cell therapy fast-tracked by FDA | ||
| 01.10. | FDA clears Novartis' oral drug for chronic hives | ||
| 01.10. | HHS staffers wait for news after government shutdown | ||
| 30.09. | Trump, Pfizer announce MFN deal; Lilly, others to come | ||
| 30.09. | Data backs Vertanical's cannabis therapy for back pain | ||
| 30.09. | New £1.2bn science park opens in Oxford | ||
| 30.09. | UK says 'online NHS hospital ' will launch in 2027 | ||
| 30.09. | AbbVie joins BMS in taking a hard line on UK drug pricing | ||
| 30.09. | PhRMA unveils DTC sales site, as more drugmakers join in | ||
| 29.09. | Enhertu scores again in early breast cancer | ||
| 29.09. | Enanta weakens on RSV treatment trial readout | ||
| 29.09. | AstraZeneca hops on the DTC sales train in the US | ||
| 29.09. | Genmab agrees $8bn takeover of cancer biotech Merus | ||
| 29.09. | Walmsley to leave GSK in surprise exit | ||
| 26.09. | FDA will review abortion pill safety - will it be impartial? |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .